Empagliflozin (Jardiance®) 10mg film-coated tablets SMC2396

Jardiance SMC guidance card index image

The production of this Guidelines summary card has been commissioned by the Boehringer Ingelheim and Lilly Alliance.

View Jardiance® (empagliflozin) prescribing and adverse event reporting information for Great Britain  and Northern Ireland.


Date of preparation: November 2021

Content for healthcare professionals

Access to this content is restricted to UK-based doctors, nurses, and pharmacists

If you are a UK-based doctor, nurse, or pharmacist, you must sign in to your account or register (for free) if you do not already have one. 

Return to homepage